Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $772,554 - $910,740
1,471 Added 8.83%
18,126 $10.6 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $6.78 Million - $9.35 Million
-15,608 Reduced 48.38%
16,655 $8.95 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $6.56 Million - $8.77 Million
-18,707 Reduced 36.7%
32,263 $15.1 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $13.2 Million - $15.5 Million
42,599 Added 508.89%
50,970 $17.5 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $10.7 Million - $12.4 Million
-33,139 Reduced 79.83%
8,371 $3.06 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $1.45 Million - $1.65 Million
-4,888 Reduced 10.53%
41,510 $13.4 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $3.78 Million - $4.43 Million
13,548 Added 41.24%
46,398 $15 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $120,865 - $150,204
515 Added 1.59%
32,850 $9.41 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1.65 Million - $2.05 Million
7,335 Added 29.34%
32,335 $8.93 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $1.11 Million - $1.36 Million
5,000 Added 25.0%
25,000 $5.78 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $896,611 - $1.16 Million
4,966 Added 33.03%
20,000 $4.59 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $872,374 - $1.13 Million
5,309 Added 54.59%
15,034 $2.81 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $1.05 Million - $1.39 Million
8,025 Added 472.06%
9,725 $1.64 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $248,574 - $287,521
1,700 New
1,700 $252,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.